课题基金 / 基金详情

Genetic and molecular studies of lymphocyte activation, immunodeficiencies and autoimmunity

Genetic and molecular studies of lymphocyte activation, immunodeficiencies and autoimmunity
淋巴细胞活化、免疫缺陷和自身免疫的遗传和分子研究
批准号:
312174
负责人:
Veillette Andr
金额:
$353.97万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-09-01 至 2021-09-01

项目摘要

项目成果

Veillette Andr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
<html> <body> <p>Many new therapies for immune disorders, such as autoimmune diseases, graft rejection and hematological malignancies,&nbsp;target receptor-initiated signaling pathways. Designing these therapies was based on mechanistic knowledge of suc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SLAMF7 in innate immune cells and anti-cancer immunotherapy
Targeting inhibitory immune checkpoints in macrophages for anti-cancer therapy
CRC Tier 1
  • 批准号:
    364798
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2016
  • 负责人:
    Veillette Andr
  • 依托单位:
SLAMF6 and 2B4: roles and modes of action in normal immunity and cancer immunotherapy
海外基金